Evidence map›Paper›PMID 31811345›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2020

Brain metabolic signatures across the Alzheimer's disease spectrum.

Arianna Sala, Camilla Caprioglio, Roberto Santangelo, Emilia Giovanna Vanoli, Sandro Iannaccone, Giuseppe Magnani, Daniela Perani

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. The impact of tau deposition and hypometabolism on cognitive impairment and longitudinal cognitive decline.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
  10. Article
  11. Observational
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. EANM procedure guidelines for brain PET imaging using [European journal of nuclear medicine and molecular imaging · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Arianna SalaVita-Salute San Raffaele University, Milan, Italy.
Camilla CaprioglioVita-Salute San Raffaele University, Milan, Italy.
Roberto SantangeloDepartment of Neurology and INSPE, San Raffaele Scientific Institute, Milan, Italy.
Emilia Giovanna VanoliNuclear Medicine Unit, San Raffaele Hospital, Via Olgettina 60, Milan, Italy.
Sandro IannacconeNeurological Rehabilitation Unit, Clinical Neurosciences Department, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.
Giuseppe MagnaniDepartment of Neurology and INSPE, San Raffaele Scientific Institute, Milan, Italy.
Daniela PeraniVita-Salute San Raffaele University, Milan, Italy. perani.daniela@hsr.it.ORCID 0000-0002-9784-292X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeGiven the challenges posed by the clinical diagnosis of atypical Alzheimer's disease (AD) variants and the limited imaging evidence available in the prodromal phases of atypical AD, we assessed brain hypometabolism patterns at the single-subject level in the AD variants spectrum. Specifically, we tested the accuracy of [

methodsWe retrospectively collected N = 67 patients with a diagnosis of typical AD and AD variants according to the IWG-2 criteria (22 typical-AD, 15 frontal variant-AD, 14 logopenic variant-AD and 16 posterior variant-AD). Further, we included N = 11 MCI subjects, who subsequently received a clinical diagnosis of atypical AD dementia at follow-up (21 ± 11 months). We assessed brain hypometabolism patterns at group- and single-subject level, using W-score maps, measuring their accuracy in supporting differential diagnosis. In addition, the regional prevalence of cerebral hypometabolism was computed to identify the most vulnerable core regions.

resultsW-score maps pointed at distinct, specific patterns of hypometabolism in typical and atypical AD variants, confirmed by the assessment of core hypometabolism regions, showing that each variant was characterized by specific regional vulnerabilities, namely in occipital, left-sided, or frontal brain regions. ROC curves allowed discrimination among AD variants and also non-AD dementia (i.e., dementia with Lewy bodies and behavioral variant of frontotemporal dementia), with high sensitivity and specificity. Notably, we provide preliminary evidence that, even in AD prodromal phases, these specific [

conclusionsThe AD variant-specific patterns of brain hypometabolism, highly consistent at single-subject level and already evident in the prodromal stages, represent relevant markers of disease neurodegeneration, with highly supportive diagnostic and prognostic role.

Indexed as

Alzheimer DiseaseBrainFluorodeoxyglucose F18HumansPositron-Emission TomographyRetrospective StudiesFluorodeoxyglucose F18[18F]FDG-PETAlzheimer’s diseaseAtypical variantsBiomarkersBrain metabolism

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.